Navigation Links
Mentice Appoints Bjorn Larsson as Vice President of Global Marketing

GOTHENBURG, Sweden, October 13 /PRNewswire/ -- Mentice, a leading supplier of solutions for medical simulation, announces the appointment of Mr. Bjorn Larsson as Vice President of Global Marketing.

Effective from today Mr. Bjorn Larsson will head up and coordinate Mentice's marketing activities globally from a corporate standpoint.

Mr. Larsson brings to Mentice over 15 years of experience of global sales, marketing and product management within pharmaceuticals and medical technology in areas including cardiology, stroke management and CNS. Before joining Mentice, he held global leadership positions at well renowned companies like Astra Zeneca, Novo Nordisk, Medtronic and Astra Tech. Mr. Larsson holds an MSc in Mechanical Engineering.

"Medical simulation is today widely endorsed for enhancing skills, improving clinical outcome and patient safety" says Mr Bjorn Larsson, Vice President of Global Marketing. He continues: "Mentice is uniquely positioned to further strengthen its leadership in this field. We are determined to provide the most innovative medical simulation solutions as an integral part of physician training and education."

"Bjorn's extensive background in the pharmaceutical and med-tech areas will clearly be a great contribution to our organisation and will help to strengthen our position in the global market place." says Goran Malmberg, President/CEO of Mentice.

Mentice - Improving Patient Safety

Mentice is a world leader in medical simulation, providing qualified solutions for training, education and assessment of medical professionals. With a focus on minimally invasive techniques and procedures, Mentice develops simulation systems for training in a virtual environment within the fields of endovascular intervention and endoscopic surgery. Mentice's solutions have documented effects of improving participants' learning, reducing costs, enhancing training effectiveness and eventually, improving patient safety.

For further information, please contact Goran Malmberg, President/CEO of Mentice, Phone: +46-31-33-99-401.

Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Mentice AB Announces Leadership Changes Within Its Worldwide Operations
2. Mentice AB Announces the Appointment of Lars Lonn as Clinical Director for Mentice
3. Mentice, Inc. and the Milwaukee Area Technical College (MATC) Announce Their Partnership in the Area of Procedural Medical Simulation
4. Mentice, Inc. and Education Management Solutions, Inc. Form OEM Partnership
5. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
6. Codexis Appoints Singapore Laboratories Managing Director
7. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
8. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
9. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
10. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
11. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
Post Your Comments:
(Date:11/25/2015)... -- Studies reveal the differences in species ... the way for more effective treatment for one of the ... --> --> Gum disease ... cats, yet relatively little was understood about the bacteria associated ... conducted by researchers from the WALTHAM Centre for Pet Nutrition ...
(Date:11/25/2015)... Nov. 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... in a fireside chat discussion at the Piper Jaffray ... . The discussion is scheduled for Wednesday, December ... .  A replay will be available for 14 ... , Julie NormartVP, Corporate Communications and Business Development ...
(Date:11/24/2015)... Nov. 24, 2015 Cepheid (NASDAQ: CPHD ... at the following conference, and invited investors to participate ...      Tuesday, December 1, 2015 at 11.00 a.m. ...      Tuesday, December 1, 2015 at 11.00 a.m. ... New York, NY      Tuesday, December ...
(Date:11/24/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) ... of the Toronto Stock Exchange, confirms that as of ... corporate developments that would cause the recent movements in ... --> About Aeterna Zentaris Inc. ... Aeterna Zentaris is a specialty biopharmaceutical company engaged ...
Breaking Biology Technology:
(Date:11/2/2015)... 2015  SRI International has been awarded a contract ... services to the National Cancer Institute (NCI) PREVENT Cancer ... expertise, modern testing and support facilities, and analytical instrumentation ... toxicology studies to evaluate potential cancer prevention drugs. ... Cancer Drug Development Program is an NCI-supported pipeline to ...
(Date:10/29/2015)... 2015  Connected health pioneer, Joseph C. Kvedar ... technology-enabled health and wellness, and the business opportunities that ... The Internet of Healthy Things . Long before ... existed, Dr. Kvedar, vice president, Connected Health, Partners HealthCare, ... moving care from the hospital or doctor,s office into ...
(Date:10/27/2015)... Oct. 27, 2015 Synaptics Inc. (NASDAQ: SYNA ... that Google has adopted the Synaptics ® ClearPad ... to power its newest flagship smartphones, the Nexus 5X ... --> --> Synaptics ... provide strategic collaboration in the joint development of next ...
Breaking Biology News(10 mins):